Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Bambusa Therapeutics prices upsized initial public offering on Nasdaq

Clinical stage biopharmaceutical firm Bambusa Therapeutics priced its upsized initial public offering on the Nasdaq Stock Market under the ticker symbol BBTX to fund antibody development

We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.

Read the original at vir.com.vn →

More in Finance & Markets

SK hynix Q4 Operating Profit Seen Surpassing 100 Trillion Won for First Time

SK hynix is poised to enter a phase of corporate revaluation, driven by growing demand for artificial intelligence (AI) memory and a large-scale shareholder return policy, according to an analysis by…

  • SK hynix projected to achieve first Q4 operating profit >100 trillion won
  • Analyst Kim Dong-won cites record earnings and undervaluation as key drivers
  • Company plans to invest 100 trillion won in shareholder return program

More from Monday 2 November →